A 12-Veteran Psilocybin Pilot Adds an Early PTSD Treatment Signal
Nine of 12 veterans met one-month response and remission thresholds in an uncontrolled pilot. The intensive, highly selected design cannot establish efficacy.
Nine of 12 veterans met one-month response and remission thresholds in an uncontrolled pilot. The intensive, highly selected design cannot establish efficacy.
FDA trial guidance and a VA–HHS research partnership, updated with the July 30 psilocybin pilot and current hearing participation information.
Insomnia, nightmares, and sleep apnea often persist with PTSD in Veterans. Evidence supports direct sleep assessment, referral, and targeted care.
VA endorses EMDR for PTSD. Veterans can ask about BHIP/general mental health, specialty PTSD care, referral, community care when eligible, and telehealth.
A clinical perspective on AIP and veteran transition, distinguishing the model from established mechanisms and PTSD treatment evidence.
The Feeling-State Addiction Protocol proposes addressing the link between smoking and positive feelings. A small conference abstract offers preliminary evidence.
End of content
End of content